Raman spectra of sodium niobate (NaNbO 3 ) were obtained in all phases and revealed a significant disorder in the high-temperature U, T2 and T1 phases and a complicated folding of the Brillouin zone at the transitions into modulated S, R, P and N phases associated with the competitive zone-boundary soft modes (in-phase and out-of phase octahedral tilts) along the M-T-R line. An extensive Raman study combined with x-ray diffraction (XRD) and dielectric measurements confirmed the presence of the incommensurate (INC) phase in sodium niobate. XRD experiments revealed the invar effect in the temperature interval 410-460 K corresponding to the INC phase associated with rotations of the NbO 6 octahedra modulated along the b-direction. Our experiments suggest that the phase P consists of three phases: monoclinic (P m ) between 250 and 410 K, INC between 410 and 460 K, and orthorhombic (P o ) between 460 and 633 K. At the low-temperature transition to the ferroelectric rhombohedral N phase all folded modes originating from the M-and T-points of the Brillouin zone abruptly disappear, Raman spectra in the N phase become much simpler and all peaks were assigned.
Piezoelectric and dielectric measurements were performed on
different batches of polarized NaNbO3 ceramics. It has been
established that, as a result of polarization, in these ceramics
there appears a metastable ferroelectric phase existing for a long
time. The presence of this phase manifests itself as a
piezoelectric effect accompanied by a piezoresonance dispersion of
the dielectric permittivity. The magnitudes and temperature
dependencies of the piezoelectric coefficients d33 of the
NaNbO3 ceramics were measured for the first time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.